Cargando…
Liposomal Bupivacaine in Implant-Based Breast Reconstruction
PURPOSE: This study evaluates the role of liposomal bupivacaine in implant-based breast reconstruction. METHODS: A prospective, randomized, single-blind trial of liposomal bupivacaine in implant-based breast reconstruction was performed. Patients in the control arm were treated with 20 mL 0.25% bupi...
Autores principales: | Motakef, Saba, Wong, Wendy W., Ingargiola, Michael J., Nguyen, David, Galdyn, Izabela A., Kim, Hahns Y., Gupta, Subhas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732669/ https://www.ncbi.nlm.nih.gov/pubmed/29263963 http://dx.doi.org/10.1097/GOX.0000000000001559 |
Ejemplares similares
-
Abstract: Liposomal Bupivacaine in Implant-Based Breast Reconstruction: Patient Outcomes and Economics
por: Motakef, Saba, et al.
Publicado: (2016) -
Abstract 27. The Use of Liposomal Bupivacaine in Patients Undergoing Abdominally-Based Autologous and Implant-Based Breast Reconstruction
por: Farias-Eisner, Gina, et al.
Publicado: (2017) -
Bupivacaine Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine Administered After Cesarean Birth
por: Mustafa, Hiba J., et al.
Publicado: (2020) -
Abstract: Liposomal Bupivacaine Reduces Postoperative Narcotic Use in Patients Undergoing Abdominal-Based Autologous and Implant-Based Breast Reconstruction
por: Farias-Eisner, Gina, et al.
Publicado: (2016) -
Liposomal bupivacaine: a review of a new bupivacaine formulation
por: Chahar, Praveen, et al.
Publicado: (2012)